1-14 of 14
Concepción Nicolás
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Importance of Early Rescue and Relative Dose-Intensity in the Salvage Therapy with Tafasitamab-Lenalidomide in Diffuse Large B-Cell Lymphoma: Real-Life Study in Spain (GELTAMO)

Antonio Gutiérrez, Izaskun Zeberio, Pilar Martinez-Barranco, Francisco Javier Peñalver, Sandra Pérez, Daniel Morillo, Xabier Mart N Martitegui, Concepción Nicolás, Ainara Ferrero, Ana Jiménez Ubieto, Mariana Bastos-Oreiro, Julio Dávila-Valls, Maria Victoria Calle Gordo, María Pérez Sala, Guillermo Rodríguez Garcia, Aranzazu Alonso Alonso, Ana Garcia Noblejas, Diana Sanchez Arguello, Teresa Knight Asorey, Maria Angeles Fernandez Fernandez, Javier López Marin, Jaime Perez de Oteyza, Sonia González De Villambrosia, Elena Perez Ceballos, Alejandro Marin, Belén Navarro, Ruben Fernandez Alvarez, Pilar Gómez, Jose Antonio Hueso, Maria Jesus Penarrubia Ponce, Pilar Bravo, Daniel García Belmonte, Haridian De La Nuez Melian, Sara Nistal, Pau Abrisqueta Costa, Fernanda Ibañez, Luis Palomera, Eva Donato, Andrea Provencio Rincon, Maria Stefania Infante, Eva Gonzalez Barca
Journal: Blood
Blood (2024) 144 (Supplement 1): 2356.
https://doi.org/10.1182/blood-2024-210868
Published: 2024
Journal Articles

Clinical Characteristics and Outcomes of Patients with Localized Stage High-Grade B-Cell Lymphoma (HGBCL) with or without MYC and BCL2 and/or BCL6 Rearrangements: A Retrospective Study from the Spanish Group Geltamo

Cristina García Herce, Anna Martín Carrizosa, Lorenzo Carita, Víctor Navarro Garces, Belén Navarro, Eva Donato, Blanca Sánchez González, Clara González Santillana, Ana Jiménez Ubieto, Luis Antonio López Gómez, Angel Serna, Ángeles Arnaldos López, Ana Garcia Noblejas, Concepción Nicolás, Rosalia Alonso Trillo, Estefania Cerezo Velasco, Daniel García Belmonte, Beatriz De La Cruz, Ana Alarcon Tomas, Francesc Bosch, Pau Abrisqueta
Journal: Blood
Blood (2024) 144 (Supplement 1): 1698.
https://doi.org/10.1182/blood-2024-201373
Published: 2024
Journal Articles

Evolution of Treatment Patterns and Sequencing in Mantle Cell Lymphoma (MCL) in Spain and Their Impact on Survival. the Geltamo-MCL-2022 Study

Ana Marin Niebla, Mariana Bastos-Oreiro, Amanda Isabel Perez, Alba Cabirta Touzón, Fatima De la Cruz Vicente, Marta Canelo, Ana Jiménez Ubieto, Sonia González De Villambrosia, Ana Muntañola, Hugo Daniel Luzardo Henríquez, Eduardo Rios Herranz, Pilar Gómez, Alberto López, Ana Saus Carreres, Alejandro Martín García-Sancho, Ana Garcia Noblejas, Carlos Grande, Pablo Prieto Martinez, Concepción Nicolás, Antonio Gutierrez, Jose-Angel Hernandez Rivas, Blanca Sánchez González, Rosalia Alonso Trillo, Eva Donato, Paola Villafuerte Gutiérrez, Daniel García Belmonte, Silvia Rocio Verdesoto Cozzarelli, Sandra Suarez Ordoñez, Emilia Pardal De La Mano, Lucia Villalon Blanco, Alicia Roldán-Pérez, Eva Gine, Juan-Manuel Sancho, Raul Cordoba, Beatriz De La Cruz, Victor Navarro Garces, Pau Abrisqueta
Journal: Blood
Blood (2024) 144 (Supplement 1): 4403.
https://doi.org/10.1182/blood-2024-209936
Published: 2024
Journal Articles

Real World Evidence of Second Line Therapy in Relapsed/Refractory Large B Cell Lymphoma: Spanish Multicenter Geltamo Study

Leyre Bento De Miguel, Mariana Bastos-Oreiro, Antonio Gutierrez, Cristina García, Almudena Cabero, Ana Jiménez Ubieto, Sonia González De Villambrosia, Alberto López, Santiago Browne, Blanca Sánchez-González, Paula Fernández-Caldas, Ana Muntañola, Belén Navarro, Ana Alarcón Tomás, Sandra Pérez, Ana Saus Carreres, Paola Villafuerte Gutiérrez, Eva Donato, Daniel García Belmonte, Jordina Rovira, Claudia Lozada, Hugo Daniel Luzardo Henríquez, Concepción Nicolás, Carlos Grande, Pau Abrisqueta, Alejandro Martín García-Sancho
Journal: Blood
Blood (2024) 144 (Supplement 1): 1715.
https://doi.org/10.1182/blood-2024-199742
Published: 2024
Journal Articles

Use of Post-Induction Treatment in Mantle Cell Lymphoma (MCL) in Spain. Do All Young Fit Patients Need Autologous Stem Cell Transplantation (ASCT) in the Era of High-Dose Ara-C (HiDAC) and Rituximab Maintenance ?

Ana Marin Niebla, Mariana Bastos-Oreiro, Amanda Isabel Perez, Alba Cabirta Touzón, Fatima De la Cruz Vicente, Marta Canelo, Ana Jiménez Ubieto, Sonia González De Villambrosia, Ana Muntañola, Hugo Daniel Luzardo Henríquez, Eduardo Rios Herranz, Beatriz De La Cruz, Raul Cordoba, Ana Saus Carreres, Alejandro Martín García-Sancho, Ana Garcia Noblejas, Carlos Grande, Pablo Prieto Martinez, Concepción Nicolás, Antonio Gutierrez, Jose-Angel Hernandez Rivas, Blanca Sánchez-González, Rosalia Alonso Trillo, Eva Donato, Paola Villafuerte Gutiérrez, Daniel García Belmonte, Silvia Rocio Verdesoto Cozzarelli, Sandra Suarez Ordoñez, Emilia Pardal De La Mano, Lucia Villalon Blanco, Eva Gine, Juan-Manuel Sancho, Alberto Lopez Garcia, Alicia Roldán-Pérez, Pilar Gómez, Victor Navarro Garces, Pau Abrisqueta
Journal: Blood
Blood (2024) 144 (Supplement 1): 4422.
https://doi.org/10.1182/blood-2024-211078
Published: 2024
Journal Articles

Genetic Subtyping Using Whole Exome Sequencing across Large B Cell Lymphoma Entities in a Series of 109 DLBCL and Plasmablastic Lymphoma Cases

Santiago Montes-Moreno, Sr., Aitana Avendaño, Sonia Gonzalez De Villambrosia, Laura Rodriguez-Merino, Jordi Morata, Raul Tonda, Estrella Carrillo-Cruz, Carlos Grande, Jose Maria Roncero, Jaime Perez De Oteyza, Concepcion Nicolas, Beatriz Rey Búa, Pau Abrisqueta, Antonio Gutierrez, Angel Ramirez, Alejandro Martin Garcia-Sancho, Eva Maria Gonzalez Barca
Journal: Blood
Blood (2023) 142 (Supplement 1): 6092.
https://doi.org/10.1182/blood-2023-179150
Published: 2023
Journal Articles

Impact of the Current Treatments on the Survival of Patients with Mantle Cell Lymphoma (MCL): A Real-Life Study on Behalf of the Spanish Group of Lymphoma (GELTAMO)

Ana Marin Niebla, Mariana Bastos-Oreiro, Alba Cabirta Touzón, Marta Canelo Vilaseca, Juan-Manuel Sancho, Ana Jimenez Ubieto, Adolfo Jesús Sáez Marín, Ana Garcia Noblejas, Pablo Prieto Martinez, Concepcion Nicolas, Carlos Grande Garcia, Hugo Daniel Luzardo Henriquez, Jose Angel Hernandez Rivas, Ana Muntanola, Rosalia Alonso Trillo, Irene Arnaiz, Eva Donato, Paola Villafuerte Gutierrez, Daniel Garcia Belmonte, Alicia Roldan Perez, Sandra Suarez Ordonez, Víctor Navarro Garces, Francesc Bosch, Pau Abrisqueta
Journal: Blood
Blood (2023) 142 (Supplement 1): 1678.
https://doi.org/10.1182/blood-2023-186101
Published: 2023
Journal Articles

Cell Free Tumor DNA for DLBCL Genotyping in a Phase II Randomized Trial Comparing Standard RCHOP Versus Brcap As First Line Treatment in Patients with Poor IPI DLBCL

Nerea Martinez, PhD, Sonia González de Villambrosia, MD, Ainara Pereña, Raul Tonda, Sergi Beltran, PhD, Marta Gut, PhD, Estrella Carrillo-Cruz, MD, Carlos Grande, MD, Alejandro Martín, MD, Concepcion Nicolas, MD, Jose Maria Roncero, MD, Maria J. Rodriguez-Salazar, MD, Jaime Perez De Oteyza, MDPhD, Eulogio Conde, MD PhD, Eva Gonzalez-Barca, Santiago Montes-Moreno, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1676.
https://doi.org/10.1182/blood-2018-99-113757
Published: 2018
Journal Articles

Long-term results of a phase 2 study of rituximab and bendamustine for mucosa-associated lymphoid tissue lymphoma

Clinical Trials & Observations
Antonio Salar, Eva Domingo-Domenech, Carlos Panizo, Concepción Nicolás, Joan Bargay, Ana Muntañola, Miguel Canales, José Luis Bello, Juan Manuel Sancho, José Francisco Tomás, María José Rodríguez, Javier Peñalver, Carlos Grande, José Javier Sánchez-Blanco, Luis Palomera, Reyes Arranz, Eulogio Conde, Mar García, Juan Fernando García, Dolores Caballero, Carlos Montalbán
Journal: Blood
Blood (2017) 130 (15): 1772–1774.
https://doi.org/10.1182/blood-2017-07-795302
Published: 2017
Journal Articles

Mutational Landscape, Clonal Evolution Patterns and Role of RAS Mutations in Relapsed Acute Lymphoblastic Leukemia

Koichi Oshima, MD PhD, Hossein Khiabanian, PhD, Ana Carolina da Silva Almeida, PhD, Gannie Tzoneva, PhD, Francesco Abate, PhD, Alberto Ambesi-Impiombato, MD PhD, Marta Sanchez-Martin, PhD, Zachary Carpenter, PhD, Alexander Penson, PhD, Arianne Perez-Garcia, PhD, Cornelia Eckert, PhD, Concepción Nicolás, MD, Milagros Balbin, Maria Luisa Sulis, MD, Motohiro Kato, MD PhD, Katsuyoshi Koh, MD, Maddalena Paganin, Giuseppe Basso, MD, Julie M. Gastier-Foster, PhD, Meenakshi Devidas, PhD, Mignon L. Loh, MD, Renate Kirschner-Schwabe, PhD, Teresa Palomero, PhD, Raul Rabadan, PhD, Adolfo A. Ferrando, MD PhD
Journal: Blood
Blood (2016) 128 (22): 4068.
https://doi.org/10.1182/blood.V128.22.4068.4068
Published: 2016
Journal Articles

Phase 2 Randomized Trial Comparing Standard RCHOP Versus Brcap (bortezomib, rituximab, cyclophosphamide, adriamycin and prednisone) As First Line Treatment in Young Patients with High-Risk Diffuse Large B-Cell Lymphoma (DLBCL). a Study from Spanish Group Geltamo

Eva González-Barca, MD PhD, Estrella Carrillo-Cruz, MD, Carlos Grande, MD PhD, Alejandro Martín, MD PhD, Mónica Coronado, MD, Santiago Montes-Moreno, MD, Santiago Mercadal, MD, Josep Maria Roncero, MD, Jaime Pérez de Oteyza, MD, Concepción Nicolás, MD, María José Rodríguez-Salazar, MD, Juan-Manuel Sancho, Luis Palomera, MD PhD, Javier López-Jiménez, MD, Carmen Albo, MD, Francisco-Javier Peñalver, MD, José Ángel Hernández, MD, Armando López-Guillermo, MD PhD, María José Ramírez, MD, Isidro Jarque, MD, Joan Bargay, MD, Miguel Canales, MD PhD, Eulogio Conde, MD PhD, Dolores Caballero, MD PhD
Journal: Blood
Blood (2016) 128 (22): 4201.
https://doi.org/10.1182/blood.V128.22.4201.4201
Published: 2016
Journal Articles

Phase 2 Randomized Trial Comparing 6 Cycles of Standard RCHOP Chemotherapy Vs 6 Cycles of Brcap (bortezomib, rituximab, cyclophosphamide, adriamicine and prednisone) As First Line Treatment in Young Patients with Poor Prognosis Diffuse Large B-Cell Lymphoma (DLBCL): Interim Analysis

Eva González-Barca, MD PhD, Estrella Carrillo, Carlos Grande, MD, Alejandro Martín, Mónica Coronado, Santiago Montes-Moreno, Jaime Perez de Oteyza, Concepción Nicolas, Juan-Manuel Sancho, Luis Palomera, MDPhD, Javier Lopez, Sr., MD PhD, Armando Lopez-Guillermo, Francisco Javier Peñalver, José Ángel Hernández, MD, Maria Jose Ramirez, Isidro Jarque, Joan Bargay, MD, Mª José Rodríguez, Miguel Canales, Carmen Albo, Maite Encuentra, Dolores Caballero
Journal: Blood
Blood (2015) 126 (23): 1514.
https://doi.org/10.1182/blood.V126.23.1514.1514
Published: 2015
Journal Articles

Outcome and Long Term Toxicity of the LNH- PRO Trial after 12 Year Median Follow-up, in Patients with Indolent Non Hodgkin's Lymphoma Who Received Immunochemotherapy with CVP and Interferon-alfa2b (IFNα2b)

Jimena Cannata-Ortiz, MD, Concepción Nicolás, MD, Ana García-Noblejas, MD, Javier Lopez, Pilar Sabin, Pilar Zamora, Maria José Requena, Reyes Arranz, MD PhD
Journal: Blood
Blood (2014) 124 (21): 4465.
https://doi.org/10.1182/blood.V124.21.4465.4465
Published: 2014
Journal Articles

Manteinance Treatment with Interferon (IFN) Is Not Necessary to Achieve Prolonged Progression Free Survival (PFS) in Patients with Indolent Non Hodgkin’s Lymphoma (NHL). Results from a Prospective Randomized Trial on 165 Patients.

Jimena Cannata, Ph, Concepcion Nicolas, PhD, Raul Cordoba Resident, Ph, Consuelo Rayon, PhD, Jose Garcia-Laraña, PhD, Javier Lopez, Ph, Guillermo Perez, Ph, Pedro Sanchez-Godoy, PhD, Pilar Garcia-Alfonso, PhD, Pilar Zamora, Ph, Jose-Maria Fernandez-Rañada, PhD, Reyes Arranz, PhD
Journal: Blood
Blood (2004) 104 (11): 1392.
https://doi.org/10.1182/blood.V104.11.1392.1392
Published: 2004